The GLP-1 agonist, liraglutide, as a pharmacotherapy for obesity GLP-1 agonist to treat obesity and prevent Cardiovascular Disease: what have we achieved so far? The GLP-1 […]

Saponins, classification and occurrence in the plant kingdom Biological activities and distribution of plant saponins Saponins and plant defence—a soap story A mechanism for the hypocholesterolaemic […]

Altered intercellular communication in lung fibroblast cultures from patients with idiopathic pulmonary fibrosis Altered intercellular communication and extracellular matrix signaling as a potential disease mechanism in […]

Dysbiosis Clinical applications of urinary organic acids. Part 2. Dysbiosis markers Mechanisms of microbe–host interaction in Crohn’s disease: dysbiosis vs. pathobiont selection Dysbiosis and the immune […]

Molecular mechanism of nrf2 activation by oxidative stress The pathways and molecular mechanisms regulating Nrf2 activation in response to chemical stress Natural Nrf2 activators in diabetes […]

SIRT1 suppresses activator protein-1 transcriptional activity and cyclooxygenase-2 expression in macrophages Sirt 1 activator inhibits the AGE-induced apoptosis and p53 acetylation in human vascular endothelial cells […]

GSK3 inhibitors: development and therapeutic potential The conundrum of GSK3 inhibitors: is it the dawn of a new beginning? Discovery and development of GSK3 inhibitors for […]

Possible anti-obesity therapeutics from nature–A review Anti-obesity drugs: past, present and future Anti-obesity drugs: a review about their effects and safety Anti-obesity action of oolong tea […]